Parametrica Management Ltd cut its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 51.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,388 shares of the health services provider’s stock after selling 17,617 shares during the period. Parametrica Management Ltd’s holdings in Select Medical were worth $289,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Select Medical by 3.9% during the second quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock valued at $152,423,000 after purchasing an additional 369,044 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Select Medical by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock valued at $159,154,000 after purchasing an additional 146,892 shares during the period. Orbimed Advisors LLC increased its position in shares of Select Medical by 51.3% during the third quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock valued at $107,107,000 after purchasing an additional 1,891,100 shares during the period. Northern Trust Corp increased its position in shares of Select Medical by 14.6% during the second quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock valued at $35,694,000 after purchasing an additional 296,087 shares during the period. Finally, Point72 Asset Management L.P. bought a new stake in shares of Select Medical during the third quarter valued at approximately $20,751,000. Institutional investors and hedge funds own 77.87% of the company’s stock.

In other Select Medical news, insider Martin F. Jackson sold 156,603 shares of the company’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $17.06, for a total value of $2,671,647.18. Following the sale, the insider now directly owns 1,790,601 shares in the company, valued at $30,547,653.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Martin F. Jackson sold 134,029 shares of the company’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total value of $2,285,194.45. Following the completion of the sale, the insider now owns 1,717,944 shares in the company, valued at $29,290,945.20. The disclosure for this sale can be found here. Insiders sold 295,955 shares of company stock worth $5,052,199 over the last quarter. Company insiders own 19.93% of the company’s stock.

SEM has been the topic of a number of research reports. Zacks Investment Research upgraded Select Medical from a “sell” rating to a “hold” rating in a research report on Saturday, January 6th. Deutsche Bank restated a “buy” rating and set a $22.00 price objective on shares of Select Medical in a research report on Monday, November 6th. ValuEngine upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Robert W. Baird restated a “buy” rating and set a $21.00 price objective on shares of Select Medical in a research report on Tuesday, October 17th. Finally, Royal Bank of Canada restated a “buy” rating and set a $19.00 price objective on shares of Select Medical in a research report on Friday, October 13th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $20.25.

Shares of Select Medical Holdings Co. (NYSE SEM) opened at $17.45 on Monday. Select Medical Holdings Co. has a 1 year low of $12.00 and a 1 year high of $19.77. The firm has a market capitalization of $2,335.24, a price-to-earnings ratio of 22.09, a price-to-earnings-growth ratio of 1.10 and a beta of 1.30. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.51 and a quick ratio of 1.51.

TRADEMARK VIOLATION WARNING: “Parametrica Management Ltd Lowers Stake in Select Medical Holdings Co. (SEM)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/05/parametrica-management-ltd-lowers-stake-in-select-medical-holdings-co-sem.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.